Skip to Content

ABL Diagnostics ABLD

Morningstar Rating
€3.18 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ABLD is trading at a 37% discount.
Price
€3.16
Fair Value
€4.63
Uncertainty
Extreme
1-Star Price
€27.59
5-Star Price
€2.74
Economic Moat
Rzdxb
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ABLD is a good fit for your portfolio.

Trading Information

Previous Close Price
€3.18
Day Range
€3.183.18
52-Week Range
€3.189.70
Bid/Ask
€2.00 / €5.00
Market Cap
€51.24 Mil
Volume/Avg
50 / 80

Key Statistics

Price/Earnings (Normalized)
45.02
Price/Sales
0.55
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.
Sector
Healthcare
Industry
Health Information Services
Stock Style Box
Small Value
Total Number of Employees
21

Valuation

Metric
ABLD
Price/Earnings (Normalized)
45.02
Price/Book Value
7.64
Price/Sales
0.55
Price/Cash Flow
Price/Earnings
ABLD

Financial Strength

Metric
ABLD
Quick Ratio
1.47
Current Ratio
2.26
Interest Coverage
Quick Ratio
ABLD

Profitability

Metric
ABLD
Return on Assets (Normalized)
3.92%
Return on Equity (Normalized)
8.45%
Return on Invested Capital (Normalized)
6.24%
Return on Assets
ABLD
See how this stock stacks up to its competitors with Morningstar Investor

Health Information Services Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
GEHC
GE HealthCare Technologies Inc Common StockPlfph$41.1 Bil
VEEV
Veeva Systems Inc Class ANdmqkphhKtkzc$37.6 Bil
MTHRF
M3 IncTfzyfph$9.6 Bil
MTHRY
M3 Inc ADRZvrvyzl$9.6 Bil
PMCUF
Pro Medicus LtdDtfwz$7.0 Bil
HQY
HealthEquity IncMmjdyf$6.9 Bil
RCM
R1 RCM IncKybr$5.5 Bil
DOCS
Doximity Inc Class ANbyphxm$5.0 Bil
TXG
10x Genomics Inc Ordinary Shares - Class AKwk$4.4 Bil
EVH
Evolent Health Inc Class AGfwk$3.7 Bil

Sponsor Center